Health News

Health News

FDA Approves VIVJOA (Oteseconazole) to Reduce the Incidence of Recurrent Vulvovaginal Candidiasis

The U.S. Food and Drug Administration (FDA) approved VIVJOA (oteseconazole) to reduce the incidence of recurrent vulvovaginal candidiasis (RVVC) in females with a history of RVVC who are NOT of reproductive potential.There are two recommended VIVJOA dosage regimens: a VIVJOA-only regimen and a fluconazole/VIVJOA regimen. VIVJOA should be administered orally […]

Chicago News Health News

Choosing Your COVID-19 Booster

1st Booster: CDC recommends a booster of either Pfizer-BioNTech or Moderna COVID-19 vaccine: [ 1 ] For most people, at least 2 months after the primary dose of J&J/Janssen COVID-19 vaccine For people who are moderately or severely immunocompromised, at least 2 months after the additional dose of Pfizer-BioNTech or Moderna […]

Health News

Updated Information on Availability and Use of Treatments for Outpatients with Mild to Moderate COVID-19 Who are at Increased Risk for Severe Outcomes of COVID-19

Distributed via the CDC Health Alert NetworkMonday, April 25, 2022, 1:00 PM ETCDCHAN-00463 SummaryThe Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to update healthcare providers, public health departments, and the public about the availability and use of recommended therapies for COVID-19 […]